Home  »  Companies   »  Benitec Biopharma Inc. (BNTC): Skating on Thin Ice...

Benitec Biopharma Inc. (BNTC): Skating on Thin Ice? We Know the Answer

Benitec Biopharma Inc. (NASDAQ:BNTC) went up by 5.56% from its latest closing price compared to the recent 1-year high of $3.34. The company’s stock price has collected 12.43% of gains in the last five trading sessions.

Is It Worth Investing in Benitec Biopharma Inc. (NASDAQ :BNTC) Right Now?

Plus, the 36-month beta value for BNTC is at 1.17. Opinions of the stock are interesting as 2 analysts out of 2 who provided ratings for Benitec Biopharma Inc. declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”

Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report


The average price from analysts is $4.00, which is $3.81 above the current price. BNTC currently public float of 25.76M and currently shorts hold a 1.30% ratio of that float. Today, the average trading volume of BNTC was 585.72K shares.

BNTC’s Market Performance

BNTC stocks went up by 12.43% for the week, with a monthly jump of 11.18% and a quarterly performance of -73.51%, while its annual performance rate touched -93.67%. The volatility ratio for the week stands at 12.98% while the volatility levels for the past 30 days are set at 12.79% for Benitec Biopharma Inc. The simple moving average for the period of the last 20 days is 8.42% for BNTC stocks with a simple moving average of -83.32% for the last 200 days.

Analysts’ Opinion of BNTC

Ladenburg Thalmann, on the other hand, stated in their research note that they expect to see BNTC reach a price target of $14. The rating they have provided for BNTC stocks is “Buy” according to the report published on April 20th, 2020.

BNTC Trading at -24.68% from the 50-Day Moving Average

After a stumble in the market that brought BNTC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -94.31% of loss for the given period.

Volatility was left at 12.79%, however, over the last 30 days, the volatility rate increased by 12.98%, as shares surge +9.89% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -56.82% lower at present.

During the last 5 trading sessions, BNTC rose by +12.43%, which changed the moving average for the period of 200-days by -93.31% in comparison to the 20-day moving average, which settled at $0.1761. In addition, Benitec Biopharma Inc. saw -92.75% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at BNTC starting from Oliveira Steven Michael, who purchase 10,553 shares at the price of $3.04 back on Dec 09. After this action, Oliveira Steven Michael now owns 1,000,000 shares of Benitec Biopharma Inc., valued at $32,126 using the latest closing price.

Oliveira Steven Michael, the 10% Owner of Benitec Biopharma Inc., purchase 37,947 shares at $3.18 during a trade that took place back on Nov 29, which means that Oliveira Steven Michael is holding 989,447 shares at $120,687 based on the most recent closing price.

Stock Fundamentals for BNTC

Current profitability levels for the company are sitting at:

  • -24457.53 for the present operating margin
  • -449.32 for the gross margin

The net margin for Benitec Biopharma Inc. stands at -24942.47. Equity return is now at value -203.70, with -151.60 for asset returns.

The liquidity ratio also appears to be rather interesting for investors as it stands at 1.90.